Press Releases Medigen Vaccine Biologics Corporation

Equities

6547

TW0006547003

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-05-05 pm EDT			5-day change	1st Jan Change
53.6 ^TWD	+2.29%		+4.48%	-23.54%

Mar. 15	Medigen Vaccine Biologics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Medigen Vaccine Biologics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

WHO Initiative Signs New Licensing Agreements On Covid-19 Technologies [press release]	23-08-29	AQ
Taiwan firm to provide free COVID-19 testing for Japan-bound visitors	22-10-26	AQ
Medigen Vaccine Biologics : Clarification on media reports	22-08-03	PU
Medigen Vaccine Biologics : Announcement of the company's resolutions on the stock dividend ex-rights base date	22-07-14	PU
Medigen Vaccine Biologics : Announcement of the Company's full receipt of cash capital increase in 2022 and the reference date of capital increase	22-07-01	PU
Medigen Vaccine Biologics : Clarification on media reports	22-06-28	PU
Medigen Vaccine Biologics : Clarification on media reports	22-06-24	PU
Medigen Vaccine Biologics : Subscription rights to the cash issue forfeited by directors of the Company reaching 50% and subscription being made available to specific persons	22-06-10	PU
Medigen Vaccine Biologics : Additional update on clinical development on MVC COVID-19 vaccine in the WHO COVID-19 Solidarity Trial Vaccines (Supplementary Announcement)	22-06-08	PU
Medigen Vaccine Biologics : The manufacturing facility of MVC EV71 Vaccine obtained PIC/S GMP certificate from the Ministry of Health and Welfare (MOHW)	22-06-07	PU
Medigen Vaccine Biologics : MVC file provisional approval application of COVID-19 Vaccine to Therapeutic Goods Administration	22-06-06	PU
Medigen Vaccine Biologics : Announcement the institution designated to collect and deposit for 1st domestic unsecured convertible corporate bonds	22-04-22	PU
Medigen Vaccine Biologics : Announcement of the company's cash capital increase subscription date and other related matters (supplemental issue price and banks information)	22-04-21	PU
Medigen Vaccine Biologics : Announcement of the company's cash capital increase subscription date and other related matters	22-04-13	PU
Medigen Vaccine Biologics : Resolution by the board of directors to distribute dividends	22-04-06	PU
BlueWillow Biologics and Medigen Vaccine Biologics Announce Positive Results for Intranasal COVID-19 Booster Candidate in Pre-clinical Studies	22-03-02	BU
Medigen Vaccine Biologics : Resolution to issue new shares for capital increase through profits by Board of Directors	22-03-01	PU
Medigen Vaccine Biologics : Board of directors has resolved to issue 1st of unsecured convertible corporate bonds	22-03-01	PU
Medigen Vaccine Biologics : Announcement of the company's board of directors resolution of cash capital increase issue of new shares	22-03-01	PU
Medigen Vaccine Biologics : The Company's 2021 consolidated financial statements have been reported to the Board of Directors	22-03-01	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Medigen Vaccine Biologics Corporation

Equities

6547

TW0006547003

Press Releases

Filters